Insider: Biller Jonathan EVP and Chief Legal Officer - VERTEX PHARMACEUTICALS INC / MA
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 17,606 | 0 | 17,606 |
| Value | $6,723,203.22 | $0.00 | $6,723,203.22 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 02/18/2025 | DDS | 1,657 | Direct | COM | $455.06 | $754,034.42 | 17,606 |
| 02/11/2025 | DDS | 3,433 | Direct | COM | $459.87 | $1,578,733.71 | 16,330 |
| 10/02/2024 | DDS | 999 | Direct | COM | $461.66 | $461,198.34 | 16,651 |
| 02/12/2024 | DDS | 1,738 | Direct | COM | $418.77 | $727,822.26 | 18,280 |
| 10/02/2023 | DDS | 610 | Direct | COM | $346.76 | $211,523.60 | 10,569 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research